Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ethan Perlstein

OTHER INVESTOR TYPE
2 INVESTMENTS
1 PORTFOLIO
Description

Dr. Ethan Perlstein is a Co-Founder and Board Member of Perlara, where he serves as Chief Executive Officer and Chief Financial Officer. He is a graduate of Harvard University in the Department of Molecular and Cell Biology with a PhD. He developed an approach to studying old drugs and discovering new drugs in model organisms called evolutionary pharmacology. He is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Primary Investor Type
Angel (individual)
Primary Office
  • 6000 Shoreline Court
  • Suite 204
  • South San Francisco, CA 94080
  • United States

Ethan Perlstein Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Hyasynth Bio 25-Jul-2017 Early Stage VC 00.000 Pharmaceuticals Generating Revenue 00000 000000000 00.0
00000000 000 29-Jun-2015 000000000000 00000 Pharmaceuticals Generating Revenue 00000 000000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ethan Perlstein’s full profile, request a free trial.

Ethan Perlstein Team (1)

Name Title Deals Funds Boards Office Contact
Info
Ethan Perlstein Ph.D Angel Investor 0 0 South San Francisco, CA